John W. Ostrominski - Concepedia

Author

John W. Ostrominski

Also Known As

Alaa AM Osman, Alberto Ortiz, Augustus Osborne, J Ostrominski, J W Ostrominski, JOHN OSTROMINSKI, JOHN W. OSTROMINSKI, John Ostrominski, John W Ostrominski, John W. Ostrominski

138

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University University of Glasgow National University of Singapore University of Missouri–Kansas City

About

John W. Ostrominski is an author at Brigham and Women's Hospital specializing in medicine, heart failure, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	456
2	Health Sciences	2	2	341
3	Nephrology	2	2	341
4	Nursing	1	1	57
5	Emergency Medicine	1	1	57

John W. Ostrominski

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020 Rahul Aggarwal, John W. Ostrominski, Muthiah Vaduganathan JAMA Metabolic DisorderCardiometabolic RiskRenal PathologyObesityMetabolic Syndrome	2024	311
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020 John W. Ostrominski, Suzanne V. Arnold, Javed Butler, JAMA Cardiology	2023	196
Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure Scott D Solomon, John W. Ostrominski, Xiaowen Wang, Journal of the American College of Cardiology	2024	91
Contemporary American and European Guidelines for Heart Failure Management John W. Ostrominski, Ersilia M. DeFilippis, Kannu Bansal, JACC Heart Failure Heart FailureCardiovascular DiseaseCardiac CareHeart Failure ManagementMedicine	2024	58
Virtual Care Team Guided Management of Patients With Heart Failure During Hospitalization Ankeet S. Bhatt, Anubodh S. Varshney, Alea Moscone, Journal of the American College of Cardiology NursingPalliative CareHeart FailureDevice TherapyRemote Patient Monitoring	2023	57
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial Scott D. Solomon, John W. Ostrominski, Muthiah Vaduganathan, European Journal of Heart Failure	2024	52
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction John W. Ostrominski, Jorge Thierer, Brian Claggett, JACC Heart Failure	2023	34
Qualitative evaluation of artificial intelligence-generated weight management diet plans Dong Wook Kim, Ji Seok Park, Kavita Sharma, Frontiers in Nutrition	2024	34
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial John W. Ostrominski, Muthiah Vaduganathan, Brian Claggett, European Journal of Heart Failure	2022	30
Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction John W. Ostrominski, Brian Claggett, Zi Michael Miao, Journal of the American College of Cardiology Metabolic SyndromeHeart FailureRenal FunctionCardiovascular DiseaseMedicine	2024	30

Page 1